A Study Of HypOlipoprotein Phenotyping And Evaluation Of Sepsis

Overview

About this study

The purpose of this study is to gain a deeper understanding of dysregulated lipoprotein/lipid metabolism in sepsis, the relevant mechanisms, and develop new diagnostic and therapeutic strategies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients meeting the Sepsis-3 definition of sepsis or septic shock4 (index and readmission) and being treated with an institutional, evidence-based guideline management bundle for sepsis within 24 hrs. The sequential organ failure assessment (SOFA) score will be used for organ failure assessment.

Exclusion Criteria:

  • Alternative/confounding diagnosis causing shock (e.g., myocardial infarction or pulmonary embolus)

  • Uncontrollable source of sepsis (e.g., irreversible disease state such as unresectable dead bowel)

  • Advanced directives limiting resuscitative efforts

  • Organ transplant recipient on immunosuppressive agents

  • Known pregnancy

  • Inability to obtain informed consent

  • HIV/AIDS with CD4 count < 200

  • Absolute neutrophil count < 500

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 03/04/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Faheem Guirgis, M.D.

Contact us for the latest status

Contact information:

Faheem Guirgis

9049531498

guirgis.faheem@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20605292

Mayo Clinic Footer